| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5c121269689cbab9b3a4548b15caf3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0621
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-38 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-545 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
| filingDate |
2017-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00d3c0cf5d8b8cf33ee7e0c745153118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce5d3e47345992e45024d95bb0c48f75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4cf2575dc7f40463c6020c378938a83 |
| publicationDate |
2021-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2017393059-B2 |
| titleOfInvention |
Method for producing corneal epithelial cell mass |
| abstract |
The present invention provides a method for producing a corneal epithelial cell mass for use in the production of a corneal epithelial cell sheet for transplantation use, said method comprising the steps of: (1) preparing a cell mass containing corneal epithelial cells; (2) subjecting the cell mass prepared in step (1) to magnetic cell separation to produce CD200-negative/SSEA-4-positive cells; and (3) bringing the cells produced in step (2) into contact with laminin selected from the group consisting of laminin having an α3 chain, laminin having an α4 chain and laminin having an α5 chain or an E8 fragment thereof to obtain adhered cells. |
| priorityDate |
2017-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |